Ribavirin

nuclear receptor subfamily 1 group D member 2 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29861209 A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders. 2018 Aug 2
2 28315743 Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. 2017 Jul 1
3 25580859 Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL-28B Gene Allele and Viral Response Trial (AG & RGT). 2015 Nov 2
4 24424305 Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection. 2014 May 1
5 25013899 Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients. 2014 1
6 23286844 How to optimize HCV therapy in genotype 2 patients. 2013 Feb 1
7 23613999 Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients. 2013 1
8 23936821 Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients. 2013 1
9 22239499 Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin. 2012 Feb 1
10 20222909 Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin. 2010 Jun 4
11 19072829 Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection. 2009 Feb 1
12 18508296 Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial. 2008 Jun 2
13 16556654 Renal vasoconstrictor responses to static exercise during orthostatic stress in humans: effects of the muscle mechano- and the baroreflexes. 2006 Jun 15 1